AMGEN DATA AT WCLC 2022 HIGHLIGHTS POTENTIAL TO DELIVER TRANSFORMATIVE MEDICINES FOR HISTORICALLY DIFFICULT-TO-TREAT LUNG CANCERS

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced three new data sets from its thoracic oncology portfolio that will be presented at the International...

Related Keywords

Qatar ,Malaysia ,Australia ,Taiwan ,Japan ,United States ,Hong Kong ,United Kingdom ,Argentina ,Brazil ,Colombia ,Austria ,United Arab Emirates ,Canada ,Mexico ,Puerto Rico ,Thailand ,Israel ,Kuwait ,Singapore ,Saudi Arabia ,Vienna ,Wien ,South Korea ,Switzerland ,Turkey ,Great Britain ,American ,Prnewswire Amgen ,Hossein Borghaei ,Megan Fox ,Jessica Akopyan ,Spira Al ,Geralds Falchook ,Bobt Li ,Davidm Reese ,Kyowa Kirin Co Ltd ,Amgen ,Drug Administration ,Beigene Ltd ,Nasdaq ,Exchange Commission ,Therapeutics Inc ,Sarah Cannon Research Institute At Health ,European Union ,Amgen Inc ,Teneobio Inc ,American Cancer Society ,Memorial Sloan Kettering Cancer Center ,Chemocentryx Inc ,First Data From ,Combinations Show Clinical Activity ,Support Ongoing Investigation ,Data Reinforce Potential ,Small Cell Lung ,International Association ,Lung Cancer ,Sarah Cannon Research Institute ,Small Cell Lung Cancer ,Combination Strategies ,Thoracic Medical Oncology ,Fox Chase Cancer ,Webcast Investor Meeting ,Investor Relations Events ,Non Small Cell ,Lung Disease ,Dow Jones Industrial Average ,Best Workplaces ,Great Place ,Five Prime Therapeutics ,Lung Cancer Survival ,Clin Cancer ,American Cancer ,What Is Lung ,